Nexplanon saw its best annual performance ever, growing 17% ex-FX in 2024 and on track to achieve $1 billion in revenue for 2025. International growth was particularly strong in the LAMERA region ...

In November 2011, Nexplanon® was released. Nexplanon has a redesigned inserter intended to minimize deep insertions. The active ingredients in the new device are unchanged; however, Nexplanon ...